These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33). Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685 [TBL] [Abstract][Full Text] [Related]
23. Exogenous CCK and gastrin stimulate pancreatic exocrine secretion via CCK-A but also via CCK-B/gastrin receptors in the calf. Le Dréan G; Le Huërou-Luron I; Gestin M; Desbois C; Romé V; Bernard C; Dufresne M; Moroder L; Gully D; Chayvialle JA; Fourmy D; Guilloteau P Pflugers Arch; 1999 Jun; 438(1):86-93. PubMed ID: 10370091 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of cholecystokinin, gastrin, CCK-A receptor, and CCK-B/gastrin receptor gene expressions in gastric cancer. Okada N; Kubota A; Imamura T; Suwa H; Kawaguchi Y; Ohshio G; Seino Y; Imamura M Cancer Lett; 1996 Sep; 106(2):257-62. PubMed ID: 8844981 [TBL] [Abstract][Full Text] [Related]
25. Regulation of growth of human gastric cancer by gastrin and glycine-extended progastrin. Iwase K; Evers BM; Hellmich MR; Guo YS; Higashide S; Kim HJ; Townsend CM Gastroenterology; 1997 Sep; 113(3):782-90. PubMed ID: 9287969 [TBL] [Abstract][Full Text] [Related]
26. Role of endogenous cholecystokinin on growth of human pancreatic cancer. Matters GL; McGovern C; Harms JF; Markovic K; Anson K; Jayakumar C; Martenis M; Awad C; Smith JP Int J Oncol; 2011 Mar; 38(3):593-601. PubMed ID: 21186400 [TBL] [Abstract][Full Text] [Related]
27. Targeting gastrin for the treatment of gastric acid related disorders and pancreatic cancer. Morton M; Prendergast C; Barrett TD Trends Pharmacol Sci; 2011 Apr; 32(4):201-5. PubMed ID: 21397342 [TBL] [Abstract][Full Text] [Related]
28. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors. Zhou W; Povoski SP; Bell RH J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864 [TBL] [Abstract][Full Text] [Related]
29. The effects of antagonists of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas. Dembiński A; Warzecha Z; Konturek SJ; Cai RZ; Schally AV J Physiol Pharmacol; 1991 Jun; 42(2):195-209. PubMed ID: 1664265 [TBL] [Abstract][Full Text] [Related]
30. Cellular localization of cholecystokinin receptors as the molecular basis of the periperal regulation of acid secretion. Schmidt WE; Schmitz F Pharmacol Toxicol; 2002 Dec; 91(6):351-8. PubMed ID: 12688378 [TBL] [Abstract][Full Text] [Related]
31. Endocytosis of gastrin in cancer cells expressing gastrin/CCK-B receptor. Tarasova NI; Wank SA; Hudson EA; Romanov VI; Czerwinski G; Resau JH; Michejda CJ Cell Tissue Res; 1997 Feb; 287(2):325-33. PubMed ID: 8995203 [TBL] [Abstract][Full Text] [Related]
32. Role of Annexin-II in GI cancers: interaction with gastrins/progastrins. Singh P Cancer Lett; 2007 Jul; 252(1):19-35. PubMed ID: 17188424 [TBL] [Abstract][Full Text] [Related]
34. Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide. Hoosein NM; Kiener PA; Curry RC; Brattain MG Exp Cell Res; 1990 Jan; 186(1):15-21. PubMed ID: 2298233 [TBL] [Abstract][Full Text] [Related]
35. Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies. Behr TM; Béhé MP Semin Nucl Med; 2002 Apr; 32(2):97-109. PubMed ID: 11965605 [TBL] [Abstract][Full Text] [Related]
36. Characterization of CCK-B/gastrin-like receptors in human gastric carcinoma. Smith JP; Shih AH; Wotring MG; McLaughlin PJ; Zagon IS Int J Oncol; 1998 Feb; 12(2):411-9. PubMed ID: 9458369 [TBL] [Abstract][Full Text] [Related]
37. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand. Chang RS; Chen TB; Bock MG; Freidinger RM; Chen R; Rosegay A; Lotti VJ Mol Pharmacol; 1989 Jun; 35(6):803-8. PubMed ID: 2733696 [TBL] [Abstract][Full Text] [Related]
38. Novel expression of gastrin (CCK-B) receptors in pancreatic carcinomas and dysplastic pancreas from transgenic mice. Povoski SP; Zhou W; Longnecker DS; Bell RH Am J Surg; 1994 Jan; 167(1):120-6; discussion 126-7. PubMed ID: 8311122 [TBL] [Abstract][Full Text] [Related]
39. Pancreatic secretory response to feeding in the calf: CCK-A receptors, but not CCK-B/gastrin receptors are involved. Le Dréan G; Le Huërou-Luron I; Gestin M; Romé V; Bernard C; Chayvialle JA; Fourmy D; Guilloteau P Can J Physiol Pharmacol; 2000 Oct; 78(10):813-9. PubMed ID: 11077982 [TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of CCK-B/gastrin receptors in human pancreatic cancer cell lines. Smith JP; Liu G; Soundararajan V; McLaughlin PJ; Zagon IS Am J Physiol; 1994 Jan; 266(1 Pt 2):R277-83. PubMed ID: 8304551 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]